ESCMID weekly news 26.05.2020

26 May 2020: ESCMID Weekly News
Having trouble viewing this email? View in your browser.


26 May 2020

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.


Upcoming ESCMID Webinar: COVID-19 – A question-based discussion on treatment

The next ESCMID Webinar on COVID-19 is coming up this Thursday, 28 May, from 18:00 – 20:00 CEST.

Follow ESCMID on Twitter or Facebook to stay up to date with the announcement of these webinars, including these other upcoming dates:

  • COVID-19 and Public Health:
    Thursday, 4 June 2020, 18:00-20:00 CEST

› Read more

ESCMID Study Group Research Grants 2020: apply now!

Also in 2020, ESCMID will support Study Group research projects in the fields of clinical microbiology and infectious diseases. The call to apply for the ESCMID Study Group Research Grants is officially opened and the deadline for submitting your applications is 27 July 2020, 17:00 CEST.

All the info regarding the ESCMID Study Group Research funding are available here.

Please carefully read the updated “What you need to apply” section: important changes have been made compared to the previous call.

› Read more

ESCMID Conference on Corona Virus Disease (ECCVID) – Emerging threats, emerging solutions

ESCMID is very pleased to announce that it will be hosting the first virtual congress specifically dedicated to COVID-19. The ESCMID Conference on Corona Virus Disease, (ECCVID), will take place across three days from Wednesday 23rd to Friday 25th September 2020, and will cover all aspects of the COVID-19 threat.

We hope you will join us for this incredible experience as we explore this global threat.

More information will follow as the conference draws nearer.

Stay up to date with the latest information by following us on our social media platforms like TwitterFacebook and LinkedIn.


ESCMID Webinars on COVID-19 – Catch the replays

Over the last month, ESCMID has conducted a series of webinars addressing various aspects of the COVID-19, including infection control, diagnosis and international perspectives.

You can watch replays of the webinars on the ESCMID E-Academy.

Follow ESCMID on
Twitter or Facebook to stay up to date with the announcement of future webinars.

› Read more


CMI highlight: A multiple center clinical evaluation of an ultra-fast single-tube assay for SARS-CoV-2 RNA

In the present study authors report a multicentre clinical evaluation of a single-tube reverse transcription recombinase-aided amplification (RT-RAA) assay for SARS-CoV-2, through analysis of 947 clinical samples from five institutions in four regions of China.

This RT-RAA kit was first launched on Jan 29, 2020 and passed the external quality assessment of National Institute for Viral Disease Control and Prevention (IVDC), Chinese Center for disease control and prevention (CCDC) and Beijing CDC.

Results obtained showed that, with comparable sensitivity and specificity to the commercial qRT-PCR kits, the RT-RAA assay for SARS-CoV-2 exhibited distinctive advantages of simplicity and rapidity in terms of operation and turn-around time.

› Read more

ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube

The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.